Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AUPH · as of Jun 8, 2026
Activity summary
Buy transactions
14
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
14.00
Buy/Sell (by trades)
Overall sentiment
Aurinia Pharmaceuticals Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
AUPH insider buying and selling by quarter
AUPH insider selling · AUPH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · AUPH ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
AUPH executive sell shares · AUPH board member insider trading · AUPH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | Robertson Stephen P. Chief Legal Officer | Award | 115,541 | — | Form 4 |
| May 18, 2026 | Hearne Michael S CFO | Award | 116,144 | — | Form 4 |
| May 18, 2026 | Cole Ryan COO | Award | 116,144 | — | Form 4 |
| Mar 6, 2026 | Keenan Greg SVP, Chief Medical Officer | Other | 8,069 | $116K | Form 4 |
| Feb 27, 2026 | Miller Joseph M CFO | Award | 57,229 | — | Form 4 |
| Mar 2, 2026 | Miller Joseph M CFO | Other | 37,511 | $533K | Form 4 |
| Feb 27, 2026 | Donley Matthew Maxwell COO | Award | 58,160 | — | Form 4 |
| Mar 2, 2026 | Donley Matthew Maxwell COO | Other | 40,761 | $579K | Form 4 |
| Feb 27, 2026 | Greenleaf Peter CEO · Director | Award | 196,403 | — | Form 4 |
| Mar 2, 2026 | Greenleaf Peter CEO · Director | Other | 100,890 | $1.43M⚡ | Form 4 |
| Feb 27, 2026 | Keenan Greg SVP, Chief Medical Officer | Award | 40,586 | — | Form 4 |
| Feb 27, 2026 | Robertson Stephen P. EVP, General Counsel | Award | 59,090 | — | Form 4 |
| Mar 2, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 36,525 | $519K | Form 4 |
| Feb 20, 2026 | Donley Matthew Maxwell COO | Other | 32,901 | $474K | Form 4 |
| Feb 20, 2026 | Greenleaf Peter CEO · Director | Other | 100,171 | $1.44M⚡ | Form 4 |
| Feb 20, 2026 | Miller Joseph M CFO | Other | 32,424 | $467K | Form 4 |
| Feb 20, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 34,638 | $499K | Form 4 |
| Feb 2, 2026 | Keenan Greg SVP, Chief Medical Officer | Other | 11,552 | $168K | Form 4 |
| Jan 2, 2026 | Robertson Stephen P. EVP, General Counsel | Award | 48,558 | — | Form 4 |
| Jan 2, 2026 | Robertson Stephen P. EVP, General Counsel | Other | 40,385 | $644K | Form 4 |
| Jan 2, 2026 | Donley Matthew Maxwell COO | Award | 54,166 | — | Form 4 |
| Jan 2, 2026 | Donley Matthew Maxwell COO | Other | 42,787 | $682K | Form 4 |
| Jan 2, 2026 | Miller Joseph M CFO | Award | 49,038 | — | Form 4 |
| Jan 2, 2026 | Miller Joseph M CFO | Other | 40,161 | $641K | Form 4 |
| Jan 2, 2026 | Greenleaf Peter CEO · Director | Award | 165,384 | — | Form 4 |
Robertson Stephen P.
Chief Legal Officer
Date
May 18
Shares
115,541
Price
—
Value
—
Keenan Greg
SVP, Chief Medical Officer
Date
Mar 6
Shares
8,069
Price
$14.32
Value
$116K
Greenleaf Peter
CEO · Director
Date
Mar 2
Shares
100,890
Price
$14.21
Value
$1.43M ⚡
Robertson Stephen P.
EVP, General Counsel
Date
Feb 27
Shares
59,090
Price
—
Value
—
Robertson Stephen P.
EVP, General Counsel
Date
Mar 2
Shares
36,525
Price
$14.21
Value
$519K
Greenleaf Peter
CEO · Director
Date
Feb 20
Shares
100,171
Price
$14.40
Value
$1.44M ⚡
Robertson Stephen P.
EVP, General Counsel
Date
Feb 20
Shares
34,638
Price
$14.40
Value
$499K
Keenan Greg
SVP, Chief Medical Officer
Date
Feb 2
Shares
11,552
Price
$14.53
Value
$168K
Robertson Stephen P.
EVP, General Counsel
Date
Jan 2
Shares
48,558
Price
—
Value
—
Robertson Stephen P.
EVP, General Counsel
Date
Jan 2
Shares
40,385
Price
$15.95
Value
$644K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AUPH insider trading
AUPH insider trades
Aurinia Pharmaceuticals Inc. (AUPH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Robertson Stephen P. (Chief Legal Officer), Miller Joseph M (CFO), Donley Matthew Maxwell (COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. AUPH insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Aurinia Pharmaceuticals Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AUPH insider trading · 5 questionsThe insiders of Aurinia Pharmaceuticals Inc. (AUPH) include executives and directors such as Robertson Stephen P. (Chief Legal Officer), Miller Joseph M (CFO), Donley Matthew Maxwell (COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026